Yeast-based protein expression systems will likely play an important role in vaccine production during future pandemics.

Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...

Non-specific Endonuclease Market to reach US$ 726.6 Bn by 2036 at 6.5% CAGR, driven by rising biotechnology research, ...

Viral vectors are a key component of many advanced gene therapies and vaccines, but reliable, large-scale manufacturing remains a significant challenge. Continued innovation in vector design, cell ...

This blog is based on the analysis Frost RadarTM: Digital Biomanufacturing of Viral Vectors Vandana Iyer from the TechVision – Health & Wellness team. As the cell and gene therapy (CGT) market ...

CDMO AGC Biologics signed a licensing agreement for Asimov’s off-the-shelf LV Edge Packaging cell line. AGC Biologics’ Cell and Gene Center of Excellence in Milan now offers a lentiviral packaging ...

Key trends include strategic CDMO partnerships and a shift to in vivo administration, enhancing accessibility and innovation ...

Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of Excellence Asimov, the synthetic biology ...

Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of Excellence BOSTON & MILAN--(BUSINESS WIRE) ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, and AGC Biologics, your friendly CDMO expert, have signed a licensing agreement for Asimov’s off-the-shelf ...